Aptamers designed to bind several targets [35,36] including nucleolin [37,38] or EPCAM [39], overexpressed in breast cancer, or aptamers selected to bind to breast cancer 4T1 cells [40], are also of relevance. This evidence concerns the gene NUCLEOLIN and breast cancer.